Ocular Therapeutix, Inc. (OCUL)
8.87
-0.63
(-6.63%)
USD |
NASDAQ |
Mar 12, 16:00
8.90
+0.03
(+0.34%)
After-Hours: 20:00
Ocular Therapeutix EPS Diluted (Quarterly) : -0.29 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Abbott Laboratories | 1.030 |
| EyePoint Plc | -0.8143 |
| Quince Therapeutics, Inc. | -0.2492 |
| Ernexa Therapeutics, Inc. | -0.1507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.65M |
| Revenue (Quarterly) | 13.25M |
| Total Expenses (Quarterly) | 77.90M |
| Enterprise Value | 1.271B |
| Gross Profit Margin (Quarterly) | 87.97% |
| Profit Margin (Quarterly) | -488.0% |
| Earnings Yield | -16.22% |
| Normalized Earnings Yield | -16.10 |